Blue Water Vaccines Inc., a Norwood startup, has entered into an exclusive worldwide license agreement with St. Jude Children’s Research Hospital to develop a vaccine for Streptococcus pneumoniae. The bacteria can cause many kinds of diseases, including the lung infection pneumonia.
“A major limitation of the currently licensed pneumococcal vaccines is the lack of efficacy against mucosal disease manifestations such as acute otitis media, acute bacterial sinusitis and pneumonia,” Blue Water stated.
Acute otitis media, an ear infection caused by Streptococcus pneumoniae, is one of the most common infectious diseases despite widespread vaccination, Blue Water noted.
Click here to read the complete article.
Story excerpt provided by Cincinnati Business Courier.
Written by Barrett J. Brunsman.
Originally published February 10, 2020.